|
 |
 |
 |
Chemotherapy Current Events | Chemotherapy News Chemotherapy current events and Chemotherapy news stories from Brightsurf. Find the latest Chemotherapy research, discoveries and most popular current news and events. |
| Page 1 of 44 | 865 Results |
|
|
| Sort By: Most Viewed Chemotherapy Current Events | Recent Chemotherapy Current Events |
Home chemotherapy is a viable alternative to hospital treatment Home chemotherapy is a safe and acceptable alternative to hospital treatment for patients with colorectal cancer that may improve compliance with treatment, according to a study in this week's BMJ. Of 87 patients receiving chemotherapy for colorectal cancer, 42 were treated at an outpatient clinic and 45 at home, over a 12-month period. The two groups were similar in terms of age, sex, site of... View More (2001-04-03)
Older and poorer bowel cancer patients not given chemotherapy Data were analysed from almost 8,000 bowel cancer patients under the age of 75, who were admitted to one of 59 hospitals in Scotland between 1990 and 1994. The results showed that 8 per cent of patients were given chemotherapy. View More (1999-11-15)
Clear guidelines on oral chemotherapy needed Current practices around the use of oral chemotherapy in US cancer centres need to be improved, say doctors in a study on bmj.com. View More (2007-01-12)
Combination Chemotherapy Best Option For Treating Relapsed Ovarian Cancer (p 2099) Results of a European study in this week's issue of THE LANCET suggest that combination treatment with paclitaxel and platinum-based chemotherapy could result in a modest but important survival benefit for women with relapsing ovarian cancer compared with women treated with platinum-based chemotherapy alone. Ovarian cancer is the fourth most common cancer among women and causes over 100,000... View More (2003-06-19)
Underutilized treatment for advanced ovarian cancer found to significantly improve survival According to a study published in the January 5 issue of the New England Journal of Medicine, women with Stage III ovarian cancer given a combination of intravenous (IV) and intra-abdominal chemotherapy, following the successful surgical removal of tumors, experienced a median survival time 16 months longer than women who received IV chemotherapy alone. View More (2006-01-05)
Newer, more intense chemotherapy with less radiation not more effective against Hodgkin's lymphoma A lower dose of radiation used to reduce side effects is not as effective as the regular dose when given with the standard chemotherapy in the treatment of Hodgkin's lymphoma patients with early, intermediate-stage disease. View More (2010-10-26)
Radiation after surgery doubles survival time for some lung cancer patients Patients with lung cancer that has spread to mediastinal lymph nodes - located between the chest, breastbone and spine - who receive radiation after surgery and chemotherapy live twice as long as patients who do not receive radiation after surgery. View More (2006-11-07)
Delaying Chemotherapy Could Be Best Treatment Option For Certain Type Of Non-hodgkin Lymphoma (p 516) Delaying chemotherapy until symptoms develop for patients with asymptomatic advanced low-grade non-Hodgkin lymphoma is confirmed as an appropriate strategy authors of a UK study in this week's issue of THE LANCET. Chemotherapy (single or aggressive combination therapy) does not cure advanced stage low-grade non-Hodgkin lymphomas, even when combined with radiotherapy. On behalf of the British... View More (2003-08-13)
Modest Survival Benefit From Chemotherapy For Patients With Glioma Brain Tumours (p 1011) Chemotherapy in addition to radiotherapy could have a modest survival benefit for the treatment of high-grade glioma, a severe form of brain cancer, conclude authors of a study in this week's issue of THE LANCET. Malignant gliomas are among the most devastating of cancers. They frequently result in profound and progressive disability, which often leads to death. Average survival time is only... View More (2002-03-20)
Some breast cancer tumors may be resistant to a common chemotherapy treatment Some breast cancer tumours may be resistant to a common chemotherapy treatment, suggests recent medical research at the University of Alberta. View More (2012-03-28)
Identifying subsets of patients who will respond to subsequent lines of chemotherapy In a study presented at the 35th Congress of the European Society for Medical Oncology (ESMO), Dr Giovanni Bernardo from Fondazione Maugeri in Pavia, Italy, presented results that suggested it may be possible to identify subsets of metastatic breast cancer patients who are likely to respond to subsequent lines of chemotherapy. View More (2010-10-11)
Combination therapy shows improvement for breast cancer patients Giving radiation therapy and chemotherapy at the same time after a lumpectomy helps keep breast cancer from returning locally. View More (2006-12-01)
High EGFR expression a predictor for improved survival with cetuximab plus chemotherapy High epidermal growth factor receptor (EGFR) expression was a good predictor of which lung cancer patients would survive longer when cetuximab (Erbitux) was added to first-line chemotherapy, according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC). View More (2011-07-05)
Order of chemotherapy, radiation has no effect on breast cancer survival For women who have had surgery for early breast cancer, it may not matter whether they receive follow-up chemotherapy before, after or during radiation therapy, according to a new review of studies. View More (2006-10-31)
Cancer conflict with chemotherapy treatment Women under the age of forty with breast cancer who are given drugs in addition to lumpectomies or radiotherapy, known as adjuvant chemotherapy, may not be benefiting from these drugs. View More (2007-10-11)
Researchers Discover New Method to Treat Cancer Research at Oxford University's Institute of Molecular Medicine has identified a novel therapeutic regimen for the treatment of cancer that provides significant advantages over the existing methods of cancer treatment. There are already a number of regimens available for treatment of cancer, including chemotherapy, which is commonly used to treat a number of different types of cancer. In most... View More (2003-03-20)
HtrA1 and resistance to chemotherapy in ovarian and gastric cancers While many cancer patients initially have a favorable response to chemotherapy for the treatment of solid tumors, resistance to treatment often develops. View More (2006-06-09)
Scientists uncover strategy able to dramatically reduce chemotherapy's side effects Researchers in Leuven (VIB/KU Leuven) have confirmed their hypothesis that normalizing blood vessels by blocking oxygen sensor PHD2 would make chemotherapy more effective. View More (2012-08-15)
Combined Chemotherapy and Radiotherapy for Cervical Cancer Could Increase Survival (p 781) A systematic review of randomised trials in the past two decades published in this week’s issue of THE LANCET concludes that women given concurrent chemotherapy and radiotherapy for cervical cancer could have an increased survival-rate of 12% compared with patients treated with radiotherapy alone. Cervical cancer is the second most common cancer affecting women, and is the main cause of... View More (2001-09-05)
Genetic predictor of breast cancer response to chemotherapy Chemotherapy is a major first line defense against breast cancer. However a patient's response is often variable and unpredictable. View More (2012-05-11)
|
|
| Page 1 of 44 | 865 Results |
|
|
| Sort By: Most Viewed Chemotherapy Current Events | Recent Chemotherapy Current Events |
|
|